Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer (Sorse)

AstraZeneca

Status: Completed

Conditions: Prostate Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT00668083

NIS-OIT-CAS-2007/1

Details and patient eligibility

About

Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer

Enrollment: 214 estimated patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• non metastatic Prostate Cancer
• previous treatment with bicalutamide 150mg
• biochemical relapse/progression

Exclusion criteria

• use of other treatments for Prostate Cancer